Cargando…

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?

Detalles Bibliográficos
Autores principales:	Amendola, Alessandra, Sberna, Giuseppe, Forbici, Federica, Abbate, Isabella, Lorenzini, Patrizia, Pinnetti, Carmela, Antinori, Andrea, Capobianchi, Maria Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046210/ https://www.ncbi.nlm.nih.gov/pubmed/32108832 http://dx.doi.org/10.1371/journal.pone.0230018

Ejemplares similares

The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection
por: Mondi, Annalisa, et al.
Publicado: (2022)

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics
por: Ammassari, Adriana, et al.
Publicado: (2014)

Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV
por: Pinnetti, Carmela, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
por: Agrati, Chiara, et al.
Publicado: (2019)

Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney–liver transplantation
por: Rozera, Gabriella, et al.
Publicado: (2022)

Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals
por: Rozera, Gabriella, et al.
Publicado: (2017)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with pol and LTR Targets in the Same Samples
por: Sberna, Giuseppe, et al.
Publicado: (2022)

Letter of concern re: “Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384–386. doi: 10.1016/j.jiac.2020.11.016.”
por: Sberna, Giuseppe, et al.
Publicado: (2021)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

Virus-Encoded Circular RNAs: Role and Significance in Viral Infections
por: Sberna, Giuseppe, et al.
Publicado: (2023)

Trend of respiratory pathogens during the COVID-19 epidemic
por: Sberna, Giuseppe, et al.
Publicado: (2020)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis
por: Ammassari, A, et al.
Publicado: (2012)

SARS-CoV-2 infection does not induce HIV viral escape in the central nervous system: A case series
por: Pinnetti, C., et al.
Publicado: (2020)

Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013–2020
por: Fabeni, Lavinia, et al.
Publicado: (2021)

Nonsuppressible viremia during HIV-1 therapy meets molecular virology
por: Emery, Ann, et al.
Publicado: (2023)

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients
por: Vergori, Alessandra, et al.
Publicado: (2021)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
por: Gomes, Samara Tatielle M., et al.
Publicado: (2017)

The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing
por: Svicher, Valentina, et al.
Publicado: (2013)

Letter of concern re: “Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. J. Clin. Virol. 2020; 129: 104543. doi:10.1016/j.jcv.2020.104543”
por: Sberna, Giuseppe, et al.
Publicado: (2020)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen
por: Amendola, Alessandra, et al.
Publicado: (2021)

HIV Virologic Failure among Patients with Persistent Low-Level Viremia in Nairobi, Kenya: It Is Time to Review the >1000 Virologic Failure Threshold
por: Nzivo, Mirriam M., et al.
Publicado: (2023)

Evaluation of the Aptima(®) HIV‐1 Quant Dx assay for HIV‐1 RNA viral load detection and quantitation in plasma of HIV‐1‐infected individuals: A comparison with Abbott RealTime HIV‐1 assay
por: Amendola, Alessandra, et al.
Publicado: (2016)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2
por: Sberna, Giuseppe, et al.
Publicado: (2022)

HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania
por: Vairo, Francesco, et al.
Publicado: (2013)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020)

Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project
por: Bordi, Licia, et al.
Publicado: (2021)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
por: Colavita, Francesca, et al.
Publicado: (2023)

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing
por: Prosperi, Mattia CF, et al.
Publicado: (2011)

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
por: Elvstam, Olof, et al.
Publicado: (2017)

Persistent Low-Level Viremia is an Independent Risk Factor for Virologic Failure: A Retrospective Cohort Study in China
por: Li, Qun, et al.
Publicado: (2021)

Viral and Host Mediators of Non-Suppressible HIV-1 Viremia
por: Mohammadi, Abbas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t64k7a7hnevaaf643engti562d